Hormonal Regulation of the p53 Tumor Suppressor Protein in T47D Human Breast Carcinoma Cell Line
Open Access
- 1 December 1995
- journal article
- Published by Elsevier
- Vol. 270 (48) , 28507-28510
- https://doi.org/10.1074/jbc.270.48.28507
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription.Proceedings of the National Academy of Sciences, 1994
- Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic MutationsScience, 1994
- How do breast cancers become hormone resistant?The Journal of Steroid Biochemistry and Molecular Biology, 1994
- The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.Proceedings of the National Academy of Sciences, 1993
- Wild-type p53 adopts a ‘mutant’-like conformation when bound to DNA.The EMBO Journal, 1993
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992
- Regulation of the specific DNA binding function of p53Cell, 1992
- Mechanisms of antihormone actionThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Identification of p53 as a Sequence-Specific DNA-Binding ProteinScience, 1991
- Progesterone metabolism in T47Dco human breast cancer cells—II. Intracellular metabolic path of progesterone and synthetic progestinsThe Journal of Steroid Biochemistry and Molecular Biology, 1986